INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$5,392
400 sh
Apr 10, 2026
Page 977 of 1737
← PrevNext →
Apr 13, 2026
traded Apr 10, 2026
+3d
SEC Form 4

Evidence

13
FM
Fettig Jeff MDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
SY
Schlaeppi YvonneDirector
ALOTAstroNova, Inc.
Grant or award
A—
2,873 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

13
BG
Bush Wesley GDirector
DOWDOW INC.
Grant or award
A—
5,127 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

12
GA
Gottschalk AdrianDirector, Chief Executive Officer
FHTXFoghorn Therapeutics Inc.
Gift
G—
47.5K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

12
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$1.71M
82.3K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

12
KE
Kao John EDirector, Chief Executive Officer
ALHCAlignment Healthcare, Inc.
Open-market sale · 10b5-1 plan
SELL$295K
13.8K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

12
MH
Meyer Seth HChief Financial Officer
HTGCHercules Capital, Inc.
Tax withholding
F$51K
3,458 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

12
LJ
Lee David J.Director, See Remarks
WBTNWEBTOON Entertainment Inc.
Tax withholding
F$108K
9,686 sh
Apr 12, 2026Apr 13, 2026
traded Apr 12, 2026
+1dSEC Form 4

Evidence

12
SV
Sankarlingam VelchamyPres. of Engineering & Product
ZMZoom Communications, Inc.
Tax withholding
F$205K
2,466 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

12
PC
Peck Kristin CDirector, Chief Executive Officer
ZTSZoetis Inc.
Grant or award
A$110K
2,777 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

11
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$24K
500 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

11
PC
Perducat CyrilSVP, Chief Technology Officer
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$78K
198 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

11
TY
Tan Anthony Ping YeowDirector, Chief Executive Officer
GRABGrab Holdings Ltd
Derivative conversion · 10b5-1 plan
C—
800.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

11
CM
Chang MichelleChief Financial Officer
ZMZoom Communications, Inc.
Option exercise · 10b5-1 plan
M—
22.2K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

11
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Open-market sale · 10b5-1 plan
SELL$892K
200.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

10
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$240K
10.0K sh
Apr 8, 2026Apr 13, 2026
traded Apr 8, 2026
+5dSEC Form 4

Evidence

9
EK
Esch KevinExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$55.28
1 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
SV
Sankarlingam VelchamyPres. of Engineering & Product
ZMZoom Communications, Inc.
Option exercise
M—
4,845 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
FC
Follmann ChristianChief Operating Officer
HTGCHercules Capital, Inc.
Tax withholding
F$21K
1,433 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
LJ
Litton Mark JamesDirector, PRESIDENT and CEO
LONALeonaBio, Inc.
Grant or award
A—
750.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
PA
Panzara Michael A.Director
LONALeonaBio, Inc.
Grant or award
A—
28.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
LB
Langan BrianSee Remarks
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
911 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
DR
Driscoll RimmaExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$1,038
26 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
MP
Monahan Michael P.Chief Financial Officer
SKINBeauty Health Co
Tax withholding
F$25K
26.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
GD
Gray James DChief Financial Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
85.4K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
KG
Krause Allyson G.General Counsel
MYNDMynd.ai, Inc.
Tax withholding
F$6,646
20.8K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
ZW
Zhang Yi WenDirector
NCRANOCERA, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
BJ
Bolton JeffreyDirector
EHABEnhabit, Inc.
Grant or award
A$37K
2,680 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
KB
Kosacz BarbaraDirector
LONALeonaBio, Inc.
Grant or award
A—
28.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
LS
Lewis SheriCSO and COO
SKINBeauty Health Co
Tax withholding
F$23K
24.9K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
HR
Hoops RobinCHIEF FINANCIAL OFFICER
BRQLDYNAMIC AEROSPACE SYSTEMS Corp
Grant or award
A—
500.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
WS
Warzala Richard SDirector
ALOTAstroNova, Inc.
Grant or award
A—
2,827 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
CK
Church KevinCHIEF SCIENTIFIC OFFICER
LONALeonaBio, Inc.
Grant or award
A—
300.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
HE
Hoeflinger ErinDirector
EHABEnhabit, Inc.
Grant or award
A$24K
1,698 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
BZ
Botelho Kiersten ZazaChief Legal Officer & CCO
HTGCHercules Capital, Inc.
Tax withholding
F$14K
956 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
RA
Romano Kelly ADirector
LONALeonaBio, Inc.
Grant or award
A—
28.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
TY
Teng Song-YuanDirector, Chief Executive Officer (Asia)
NCRANOCERA, INC.
Grant or award
A—
600.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
SB
Strand Michael B.Chief Revenue Officer
MYNDMynd.ai, Inc.
Tax withholding
F$1,349
4,216 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
MH
Meyer Seth HChief Financial Officer
HTGCHercules Capital, Inc.
Tax withholding
F$44K
3,011 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence